Supply chains for the vaccine manufacturers must be kept open: Piyush Goyal

Goyal and Tai discussed measures to increase vaccine availability in an inclusive and equitable manner to fight the pandemic

Piyush Goyal
Piyush Goyal | File Photo: PTI
Shreya Nandi New Delhi
2 min read Last Updated : May 14 2021 | 8:55 PM IST
Supply chains for the vaccine manufacturers must be kept open and unbridled as the entire world is in dire need of the shots, union commerce and industry minister Piyush Goyal told US Trade Representative (USTR) Katherine Tai in a virtual meeting.

A week after the US backed a temporary waiver of intellectual property protection for Covid-19 vaccines to help end the global pandemic, Goyal and Tai discussed measures to increase vaccine availability in an inclusive and equitable manner to fight the pandemic.

“Had a fruitful discussion with US Trade Representative AmbassadorTai focusing on India & US working together on Trade-Related aspects of Intellectual Property Rights (TRIPS) waiver. This will ensure affordable COVID-19 vaccines for all,” Goyal said in a tweet on Friday.

The proposal of India on waiver of certain Trade Related Aspects of Intellectual Property Rights (TRIPS) provisions to increase global vaccine production in order to take on the challenge of vaccinating the poorest of the poor and saving lives was also discussed, an official statement said.

In October last year, India and South Africa had submitted a joint proposal for waiving some sections of the TRIPS agreement, including copyrights, patents, to help more countries, especially middle and low income nations to access vaccines, amid the Covid-19 crisis. The developed nations have opposed the proposal that has received the support of three-fourth of all the member nations at the WTO till now.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusPiyush GoyalCoronavirus TestsCoronavirus Vaccine

Next Story